What If Kamala Wins? The 3 Words That Will Change Everything

The same team that predicted Biden's downfall ... now warns of a new threat. Learn how to safeguard your future.

Popular

The Only Thing a New President Won't Do - Ad

One thing's for sure: A new president is probably NOT going to make you wealthy. If you want to build wealth and secure your financial future, that's something only you can control. And I've uncovered a simple strategy that can help anyone grow their wealth ahead of the 2024 elections.

Judge allows smoking to continue in Atlantic City casinos, dealing blow to workers

ATLANTIC CITY, N.J. (AP) — A judge on Friday allowed smoking to continue in Atlantic City’s casinos, giving some measure of relief to the city's struggling casino industry while rebuffing workers who have long sought to be able to breathe clean air on the casino floor.

WHO and Africa CDC launch a response plan to the mpox outbreak

DAKAR, Senegal (AP) — The Africa Center for Disease Control and Prevention and the World Health Organization launched on Friday a continent-wide response plan to the outbreak of mpox, three weeks after WHO declared outbreaks in 12 African countries a .

My TOP Altcoin for Right Now Is... - Ad

Searching for the top investment opportunity in crypto? Look no further. Our $3 report gives you the full scoop. You'll get this exciting token's name, our recommended investment strategy, and growth projections. Time is of the essence with this one...

Sen. Bernie Sanders said he is set to pursue contempt charges against Steward CEO

BOSTON (AP) — Vermont U.S. Sen. Bernie Sanders said Wednesday he is prepared to pursue contempt charges against Steward Health Care CEO Ralph de la Torre if he fails to show up at a hearing Thursday

Nuvalent Stock Jumps On ESMO Data Presentation, Seeks To Raise $350M Via Equity

Nuvalent presented updated Phase 1 data from its ARROS-1 and ALKOVE-1 trials at the ESMO Congress 2024. Key data showed promising response rates in pretreated patients, with pivotal results expected in 2025.

Kamala Harris May Seize This Cutting-Edge Tech -- Act Now - Ad

A new technology (not AI) is powerful enough to save America $1.7 TRILLION in healthcare costs each year. Trump is rumored to use it personally... And Kamala Harris has threatened to have key patents on it seized. Whoever wins the election - it could cause a massive surge in demand... And send a tiny firm with key patents on this technology soaring. It's currently trading for only $7. But it likely won't stay this cheap for long.

Moderna Faces Analyst Downgrades Amid Revised R&D Restructured Strategy and Delayed Profitability Target

Moderna announces plans to reduce R&D spending by $1.1 billion by 2027, focusing on ten key products. Analysts highlight near-term challenges, lowered price targets, and a delayed breakeven to 2028, with optimism around Moderna's oncology pipeline and long-term platform potential.

Congress targets Chinese influence in health tech. It could come with tradeoffs

WASHINGTON (AP) — A California that helps doctors detect genetic causes for cancer is among those that could be cut out of the U.S. market over ties to China, underscoring the possible tradeoffs between health innovation and a to counter Beijing's global influence.

What Smart Investors Are Doing to Profit From the Election - Ad

While millions of Americans are fighting over who they want to win the presidential election... A small group of folks are quietly positioning themselves to profit from it by following a simple election playbook.

How social media became a storefront for fake pills as families struggle

Fentanyl overdoses have become for minors in the last five years or so, even as overall drug use has dropped slightly. In a 2022 analysis of fentanyl-laced prescription pills, the contained a potentially lethal dose of the drug.

US-based researchers win $1 million prize for their work on face recognition

LISBON, Portugal (AP) — Four researchers working in the United States are sharing a $1 million prize from a Portuguese foundation for their work on how the human brain distinguishes faces, shapes and colors.

A New Drug Set to Outgrow Zoloft and Metformin--Invest Now - Ad

A new breakthrough drug is predicted to hit 250 million subscriptions in the next SIX YEARS, according to Morgan Stanley. Even better, a tiny company - trading for only $7 - holds key patents on this new drug. But it won't stay under the radar for much longer.

Stryker Unveils New Foot & Ankle Solutions With Truss Implants: Details

Stryker Corporation announced new Foot & Ankle products from 4WEB Medical, with analysts maintaining positive ratings.

Biden Administration Finalizes Rule To Expand Mental Health Care Access: How This Could Impact The Psychedelics Industry

Biden's new mental health rule expands access to treatment, including potential insurance coverage for psychedelic-assisted therapies, shaping the future of mental health care.

What Kamala Won't Do if She Wins the Election - Ad

She's promising to bring down housing costs and grocery prices...But the one thing she probably won't do, is make you wealthier. Ex-Wall Street Insider, Adam O'Dell has identified a simple way for any American to grow their wealth going into the 2024 presidential elections.

AP Lifestyles Digest for week of Sept. 9

Here is the AP Lifestyles Digest for the week of Sept. 9:

U.S. Loses to China in Shocking WAR GAMES - Ad

Pentagon says new "living missile" key to winning a future conflict. Investors stand to reap 35,960% on shares of the small defense contractor that makes powerful new weapon.

JP Morgan Shows Most Interest In Teva, Organon As Specialty Pharma Sector Exhibits Signs Of Stability

JP Morgan assesses the specialty pharma sector, highlighting robust fundamentals and new product excitement. Key focus on Teva, Organon, and Viatris.

AP Weekend News Lookahead - September 7-9

This news lookahead offers a look at major events and stories through the weekend and beyond. All times EDT and plans are subject to change. Find our latest plans in .

4 Cryptos Set to Outperform Bitcoin in 2024 - Ad

Chris Rowe, the man who spotted 44 different coins that have returned over 100%, is now making the biggest crypto call of his ENTIRE career.... Because a powerful crypto event will trigger on June 24th... Sending hundreds of tiny cryptos soaring 5X, 50X, even 100X -- in just days.

Teen vaping hits 10-year low in the US

WASHINGTON (AP) — Fewer adolescents are this year than at any point in the last decade, government officials reported Thursday, pointing to a of high school students who are using Elf Bar and other fruity, unauthorized e-cigarettes.

Fake Ozempic Targets Weight-Loss Market: Forged Batches An International Concern

Criminals distribute fake Ozempic by forging batch numbers. Novo Nordisk suspects one source in global counterfeiting operation. Other drugs also affected.

America Can't Afford a Harris Presidency - Ad

New research from Jim Rickards - former advisor to the CIA - reveals shocking predictions about an "Election Meltdown" coming this November. Jim's showing all American patriots why an "Election Meltdown" could crash stocks by 50%, lead to the final demise of the dollar, even cause violent riots in the streets.

Sanofi Still Bets On Multiple Sclerosis Med Tolebrutinib Despite The Investigational Drug Fell Short In 2 Of 3 Phase 3 Trials

Sanofi's phase 3 HERCULES study data shows tolebrutinib met the primary endpoint in delaying disability progression in non-relapsing secondary progressive multiple sclerosis.

Chocolate's future could hinge on success of growing cocoa not just in the tropics, but in the lab

WEST SACRAMENTO, Calif. (AP) — Climate change is stressing rainforests where the highly sensitive cocoa bean grows, but chocolate lovers need not despair, say companies that are researching other ways to grow cocoa or develop cocoa substitutes.

Exposed: Democrats' Secret Plan to Keep Trump Out of the White House - Ad

Former advisor to the CIA, the Pentagon and the White House Jim Rickards just released this shocking new video exposing Democrats' secret plan to keep Trump out of the White House... Even if he wins the election. See the details and learn how to prepare... Because this could trigger the biggest constitutional crisis in our nation's history.

US clears updated COVID shots from Novavax, adding a 3rd fall vaccine option

U.S. regulators have cleared a third updated COVID-19 vaccine for this fall, shots made by Novavax Inc.

Mpox Vaccine: Emergent BioSolutions' Smallpox Vaccine Gets FDA Nod For Expanded Use For Individuals At High Risk Of Mpox Infection

The FDA has approved Emergent BioSolutions' supplemental Biologics License Application for ACAM2000 to include the prevention of mpox disease in high-risk individuals, with the approval based on human safety data and animal studies.

Auditor faults Pennsylvania agency over fees from Medicaid-funded prescriptions

HARRISBURG, Pa. (AP) — A review by Pennsylvania's elected financial watchdog concluded there were shortcomings in a state agency's oversight of fees paid to pharmacy benefit managers in the Medicaid program, but the claims were hotly disputed by state officials.

Body of Delta Air Lines worker who died in tire explosion was unrecognizable, son says

ATLANTA (AP) — The body of a worker at a Delta Air Lines maintenance facility near the Atlanta airport was unrecognizable, and the family relied on tattoos and a lanyard to identify him, his son told a news outlet.

A 10,000% Dividend?!? - Ad

Have you seen this strange oil investment? It's NOT a stock, bond, or private company...It has NO age requirements...You do NOT need to be accredited to participate... And you can get in for as little as $25.

Diagnostic Giants Labcorp, Roche To Ramp Up Testing Capacity Amid Global Concerns Over New Mpox Strain

Labcorp considers boosting its mpox testing capacity as the WHO declares a global health emergency. Companies like Roche and Quest Diagnostics are also monitoring demand and expanding testing services.

Belgium-Based Pharma Firm UCB To Offload China Neurology, Allergy Business For $680M To Asset Management Companies

UCB announces a $680 million strategic divestment deal in China, selling its neurology and allergy business to CBC Group and Mubadala while focusing on innovative therapies in the region.

Recommended

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright priceactionea.net
Privacy Policy | Terms of Service